Category Archives: Nonmedicinal drugs
The effect of non-injection drug use on sexual risk behaviours and ART adherence among men who have sex with men
Key take-home messages Some men who have sex with men may use various substances to overcome negative emotions, alleviate social unease, or enhance sexual experiences. The majority of studies focus...
Challenges faced by HIV-positive youth transitioning to adult care and evidence-based practices to address them
Key take-home messages The barriers to successful transition to adult HIV care include lack of preparation, psychosocial stressors, loss of relationships, stigma, and barriers within the adult health care system...
Tuberculosis infection and disease in people living with HIV in countries with low tuberculosis incidence
In countries with low tuberculosis (TB) incidence, TB is concentrated in vulnerable populations, including people living with the human immunodeficiency virus (PLHIV), who have a substantially greater risk of TB...
Predictors of human immunodeficiency virus (HIV) infection in primary care among adults living in developed countries: A systematic review
BACKGROUND: Early diagnosis of human immunodeficiency virus (HIV) is important because antiretroviral therapies are more effective if infected individuals are diagnosed early. Diagnosis of HIV relies on laboratory testing and...
Health risk behaviour among adolescents living with HIV in Sub-Saharan Africa: A systematic review and meta-analysis
The burden of health risk behaviour (HRB) among adolescents living with HIV (ALWHIV) in sub-Saharan Africa (SSA) is currently unknown. A systematic search for publications on HRB among ALWHIV in...
Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review
BACKGROUND: Injection drug use (IDU) in nonurban areas of the United States is a growing public health concern, but there has been no comprehensive assessment of existing research on injection-related...
Integrated models of care for individuals with opioid use disorder: How do we prevent HIV and HCV?
PURPOSE OF REVIEW: To describe models of integrated and co-located care for opioid use disorder (OUD), hepatitis C (HCV), and HIV. RECENT FINDINGS: The design and scale-up of multidisciplinary care...
Barriers to antiretroviral therapy adherence in developed countries: A qualitative synthesis to develop a conceptual framework for a new patient-reported outcome measure
Suboptimal adherence to antiretroviral therapy (ART) remains common. Patient-centered tools are needed to comprehensively assess adherence barriers in HIV clinical practice. Thus, we conducted a research synthesis to produce a...
